Literature DB >> 2316026

Low-dose (one gray) total-lymphoid irradiation for extensive, drug-resistant chronic graft-versus-host disease.

G Socie1, A Devergie, J M Cosset, J Y Pierga, H Esperou, T Girinski, E Gluckman.   

Abstract

Mesh：

Year:  1990        PMID： 2316026     DOI： 10.1097/00007890-199003000-00038

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  4 in total

Review 1.  Management of graft-versus-host disease in paediatric bone marrow transplant recipients.

Authors:  M Zecca; F Locatelli
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

Review 2.  Therapy of chronic graft-versus-host disease.

Authors:  Mukta Arora
Journal:  Best Pract Res Clin Haematol       Date:  2008-06       Impact factor: 3.020

3.  Treatment of severe chronic graft-versus-host disease with decidual stromal cells and tracing with (111)indium radiolabeling.

Authors:  Tom Erkers; Helen Kaipe; Silvia Nava; Pia Molldén; Britt Gustafsson; Rimma Axelsson; Olle Ringdén
Journal:  Stem Cells Dev       Date:  2015-01-15       Impact factor: 3.272

4.  Ketotifen therapy in chronic graft-versus-host disease (cGVHD): effect on mast cells and fibroblasts.

Authors:  A Nagler; V Segal; S Slavin; F Levi-Schaffer
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.